Distribution and elimination of clenbuterol in tissues and fluids of calves following prolonged oral administration at a growth‐promoting dose
- 1 April 1995
- journal article
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 18 (2) , 81-86
- https://doi.org/10.1111/j.1365-2885.1995.tb00559.x
Abstract
A pharmacokinetic study is described in which Friesian calves (n = 30) were treated orally with clenbuterol at 10 times the therapeutic dose. The study was designed to establish the distribution and elimination of clenbuterol from edible tissues, the major compartments of the eye and body fluids. Animals (n= 24) were dosed (10 μg/kg body weight) twice daily with clenbuterol for 21 days and slaughtered in groups of five (one untreated control animal per group) at 6 h and 1, 2, 4, 8 and 16 days after cessation of treatment At slaughter, samples of diaphragm muscle, liver, kidney, bile, urine and both eyes were obtained. One of the eyes was separated into constituent tissues: aqueous humour, vitreous humour, comea, lens, retina (without pigmented epithelium), choroid (with pigmented retinal epithelium; choroid/PRE) and sclera. All samples were stored at -20°C. Clenbuterol concentrations were higher in liver than kidney, bile and urine from day 2 of withdrawal onwards. Concentrations in choroid/PRE were at least 10 times higher than in liver at all periods following cessation of treatment and 52 times higher 16 days after treatment The concentrations of clenbuterol in the constituent tissues of the eye were in the order choroid/PRE > comea > sclera > retina > aqueous humour/vitreous humour ≥ lens. Concentrations of clenbuterol in choroid/PRE taken from eyes frozen whole were generally lower than those in choroid/PRE separated before storage. Choroid/PRE stored by either method contained clenbuterol at more than 100 ng/g 16 days following cessation of treatment These data suggest that analysis of choroid taken at the abattoir would provide reliable surveillance information on the use or abuse of clenbuterol within the slaughter population. It is proposed that liver samples taken concurrently could be used in the event of a positive result from choroid/PRE analysis to indicate whether the maximum residue limit for edible tissues has been exceeded.Keywords
This publication has 10 references indexed in Scilit:
- Determination of clenbuterol in bovine liver by enzyme immunoassayAnalytica Chimica Acta, 1993
- Determination of clenbuterol in bovine urine by enzyme immunoassay following concentration and clean-up by immunoaffinity chromatographyAnalytica Chimica Acta, 1993
- Determination of clenbuterol residues in bovine liver, urine, and eye by enzyme immunoassayAnalytica Chimica Acta, 1993
- Improved detection of the beta-agonist clenbuterol by analysis of retina extractsVeterinary Record, 1993
- Residues of the beta‐agonist clenbuterol in tissues of medicated farm animalsFood Additives & Contaminants, 1993
- Determination of clenbuterol in bovine tissues and urine by enzyme immunoassayJournal of Agricultural and Food Chemistry, 1992
- The pharmacokinetics and residues of clenbuterol in veal calvesJournal of Animal Science, 1991
- Development of a specific radioimmunoassay for the detection of clenbuterol residues in treated cattleFood Additives & Contaminants, 1991
- Beta-agonists as repartitioning agents: a reviewVeterinary Record, 1989
- Ocular accumulation and toxicity of certain systemically administered drugsJournal of Toxicology and Environmental Health, 1977